NETTER-1 Phase III in Patients With Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate: Efficacy, Safety, QoL Results, and Subgroup Analysis Strosberg, J., Wolin, E., Chasen, B., Kulke, M., Bushnell, D., Caplin, M., Baum, R., Kunz, P., Hobday, T., Hendifar, A., Oberg, K., Sierra, M., Kwekkeboom, D., Ruszniewski, P., Krenning, E. LIPPINCOTT WILLIAMS & WILKINS. 2017: 440

View details for Web of Science ID 000394448600073